Results 161 to 170 of about 5,685 (219)

Complications and Management of Eptifibatide-Induced Thrombocytopenia

The Annals of Pharmacotherapy, 2021
Background Eptifibatide is used in acute coronary syndromes to reversibly block platelet aggregation by inhibiting the platelet glycoprotein IIb/IIIa receptor.
Faisal Masood, Saad Hashmi, A. Chaus, Anna Hertsberg, E. Ehrenpreis   +4 more
semanticscholar   +2 more sources

Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial.

Revista Española de Cardiología, 2022
INTRODUCTION AND OBJECTIVES To study the impact of injecting intracoronary eptifibatide plus vasodilators via thrombus aspiration catheter vs thrombus aspiration alone in reducing the risk of no-reflow in acute ST-elevation myocardial infarction (STEMI ...
M. Hamza, I. Elgendy
semanticscholar   +2 more sources

Eptifibatide

Reactions Weekly, 2012
Golongan penghambat GP IIb/IIIa merupakan salah satu antiplatelet tambahan yang dapat diberikan pada pasien acute coronary syndrome khususnya pada pasien yang menjalani Percutaneous Coronary Intervention (PCI) selain penggunaan aspirin dan ...
Presley, Bobby
core   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Delayed-onset eptifibatide-induced thrombocytopenia.

American Journal of Health-System Pharmacy, 2023
DISCLAIMER In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and ...
Travis R. Huffman, Evan Gleaves, Glee Lenoir, Rahil Rafeedheen   +3 more
semanticscholar   +1 more source

A double-blinded randomized controlled trial comparing eptifibatide bolus only versus bolus plus infusion in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Cardiovascular Revascularization Medicine, 2023
BACKGROUNDS The use of eptifibatide combined with heparin during percutaneous coronary intervention (PCI) in patients presenting with ST-elevation myocardial infarction (STEMI) is recommended to be followed by continuous infusion.
M. Mousavi, Fatemeh Sehati, A. Tayebi, Alireza Dehghan Nayeri, M. Movahed   +4 more
semanticscholar   +1 more source

Safety and efficacy of eptifibatide in acute ischemic stroke requiring extracranial carotid artery stenting

Interventional Neuroradiology, 2023
Background The antiplatelet management in acute ischemic stroke requiring carotid artery stenting is heterogenous, with no clear guidelines to direct management. Objective To evaluate the safety and efficacy of an intravenous eptifibatide protocol in the
M. Waters, J. Vargas, A. Turk, I. Chaudry, R. Turner   +4 more
semanticscholar   +1 more source

Simple fabrication of eptifibatide stabilized gold nanoclusters with enhanced green fluorescence as biocompatible probe for in vitro cellular imaging

Sensors and Actuators B: Chemical, 2017
Hong Huang, Ai-Jun Wang, Hui Feng
exaly   +2 more sources

Safety and Efficacy of Periprocedural Bridging With Cangrelor Versus Eptifibatide

Journal of Cardiovascular Pharmacology, 2021
: Patients with percutaneous coronary interventions undergoing procedures often require interruptions in their dual antiplatelet therapy. Periprocedural bridging is considered for patients at high thrombotic risk using intravenous cangrelor, a reversible
Allison N. Yun, A. Toyoda, Edmond J. Solomon, R. Roberts, Christine S. Ji   +4 more
semanticscholar   +1 more source

Adjunctive treatment with low dose intra-arterial eptifibatide and intravenous aspirin during carotid stenting: A case series.

Journal of clinical neuroscience, 2021
PURPOSE According to most guidelines, medical protocol for carotid stenting includes the administration of oral Aspirin and Clopidogrel at least four days before the procedure, with intraprocedural intravenous (IV) heparin.
A. Horev, Y. Zlotnik, V. Borodetsky, Ron Biederko, M. Star, V. Zvenigorodsky, I. Shelef, G. Ifergane   +7 more
semanticscholar   +1 more source